111 related articles for article (PubMed ID: 11077000)
1. Chromosomal aberrations and micronuclei in lymphocytes of patients before and after exposure to anti-tuberculosis drugs.
Masjedi MR; Heidary A; Mohammadi F; Velayati AA; Dokouhaki P
Mutagenesis; 2000 Nov; 15(6):489-94. PubMed ID: 11077000
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
4. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
Wilkinson D; Pillay M; Davies GR; Sturm AW
Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
[TBL] [Abstract][Full Text] [Related]
5. Protein Binding of First-Line Antituberculosis Drugs.
Alghamdi WA; Al-Shaer MH; Peloquin CA
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735566
[TBL] [Abstract][Full Text] [Related]
6. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
[TBL] [Abstract][Full Text] [Related]
7. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
8. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
Putim C; Phaonakrop N; Jaresitthikunchai J; Gamngoen R; Tragoolpua K; Intorasoot S; Anukool U; Tharincharoen CS; Phunpae P; Tayapiwatana C; Kasinrerk W; Roytrakul S; Butr-Indr B
Arch Microbiol; 2018 Mar; 200(2):299-309. PubMed ID: 29119205
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of the action of drugs in the short-course chemotherapy].
Mitchison DA
Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
[No Abstract] [Full Text] [Related]
11. Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group.
Angarano G; Carbonara D; Costa D
New Microbiol; 1995 Jan; 18(1):69-72. PubMed ID: 7760759
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Liu Z; Shilkret KL; Finelli L
Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
[TBL] [Abstract][Full Text] [Related]
13. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
[TBL] [Abstract][Full Text] [Related]
14. Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions.
Kielland LG; Vage RA; Eide GE; Sørnes S; Naess A
Chemotherapy; 2011; 57(4):339-44. PubMed ID: 21912116
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro.
Zeis BM
Chemotherapy; 1988; 34(1):56-60. PubMed ID: 2832129
[TBL] [Abstract][Full Text] [Related]
16. Rationale for chemotherapy of tuberculosis and current recommendations.
Kumar L
Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
[No Abstract] [Full Text] [Related]
17. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
18. Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy.
Roman IC; Vainer E; Socosan I; Drăghicescu T
Hum Genet; 1983; 63(2):191-2. PubMed ID: 6840764
[TBL] [Abstract][Full Text] [Related]
19. Frequency and antibiotic susceptibility pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases.
Butt T; Kazmi SY; Ahmad RN; Mahmood A; Karamat KA; Anwar M
J Pak Med Assoc; 2003 Aug; 53(8):328-32. PubMed ID: 14558735
[TBL] [Abstract][Full Text] [Related]
20. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
